NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
$32.46
-3.63%
-1.19
Notify me if price changes either direction
Buy NAMS stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
3.7B
Enterprise value
3.2B
Trailing PE
-18.31685997719
Forward PE
-24.331558
PEG Ratio
-1.0379553987074
Enterprise to EBITDA
-14.809
Enterprise to revenue
141.067
Price to book MRQ
5.2477403
Price to sales TTM
162.417
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
22.6M
EBITDA
-214948000
Diluted EPS TTM
-1.78
Total Cash (MRQ)
636.1M
Current ratio (MRQ)
9.76
Operating Cash Flow (TTM)
-141919008
NAMS trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
June 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
